189
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Age-Dependent Disparities in the Prevalence of Single and Clustering Cardiovascular Risk Factors: A Cross-Sectional Cohort Study in Middle-Aged and Older Adults

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 161-169 | Published online: 05 Feb 2020

References

  • Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315–2381. doi:10.1093/eurheartj/ehw10627222591
  • WHO. Cardiovascular Diseases (Cvds). WHO Available from: http://www.who.int/cardiovascular_diseases/en/. Accessed 63, 2019.
  • Gersh BJ, Sliwa K, Mayosi BM, Yusuf S. Novel therapeutic concepts * The epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J. 2010;31(6):642–648. doi:10.1093/eurheartj/ehq03020176800
  • Doryńska A, Polak M, Kozela M. Cardiovascular disease risk factors in Kraków and in the whole Poland adult population results from the WOBASZ study and Polish arm of the HAPIEE project. Epidemiol Rev. 2015;69:175–180.
  • Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet Lond Engl. 2004;364(9438):937–952. doi:10.1016/S0140-6736(04)17018-9
  • O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112–123. doi:10.1016/S0140-6736(10)60834-320561675
  • Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–1847. doi:10.1161/01.CIR.97.18.18379603539
  • Tao M, Pi X, Ma X, et al. Relationship between serum uric acid and clustering of cardiovascular disease risk factors and renal disorders among Shanghai population: a multicentre and cross-sectional study. BMJ Open. 2019;9(3):e025453. doi:10.1136/bmjopen-2018-025453
  • Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. J Am Coll Cardiol. 1999;34(4):1348–1359. doi:10.1016/S0735-1097(99)00387-310520820
  • Kong X-L, Ma X-J, Zhang C-Y, Xu D-M. Clustering of major cardiovascular risk factors is associated with arterial stiffness in adults. Chronic Dis Transl Med. 2018;4(4):254–259. doi:10.1016/j.cdtm.2018.02.00530603743
  • Wu J, Cheng X, Qiu L, et al. Prevalence and clustering of major cardiovascular risk factors in China. Medicine (Baltimore). 2016;95(10). doi:10.1097/MD.0000000000002712
  • Hong X, Ye Q, He J, et al. Prevalence and clustering of cardiovascular risk factors: a cross-sectional survey among Nanjing adults in China. BMJ Open. 2018;8(6). doi:10.1136/bmjopen-2017-020530
  • Gao B, Zhang L, Wang H. Clustering of major cardiovascular risk factors and the association with unhealthy lifestyles in the Chinese adult population. PLoS One. 2013;8:6. doi:10.1371/journal.pone.0066780
  • Birch J, Petty R, Hooper L, Bauld L, Rosenberg G, Vohra J. Clustering of behavioural risk factors for health in UK adults in 2016: a cross-sectional survey. J Public Health. 2018. doi:10.1093/pubmed/fdy144
  • Yu J, Ma Y, Yang S, et al. Risk factors for cardiovascular disease and their clustering among adults in Jilin (China). Int J Environ Res Public Health. 2016;13(1). doi:10.3390/ijerph13010070
  • Tadayon S, Wickramasinghe K, Townsend N. Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease? Popul Health Metr. 2019;17. doi:10.1186/s12963-019-0187-7
  • Lloyd-Sherlock P, Ebrahim S, Martinez R, McKee M, Ordunez P. Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15. Lancet Glob Health. 2019;7(5):e604–e612. doi:10.1016/S2214-109X(19)30069-531000130
  • Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease. J Physiol. 2016;594(8):2061–2073. doi:10.1113/JP27053826391109
  • Akgöz A, Gözüm S. Cardiovascular disease risk in Turkish family health centers. J Vasc Nurs off Publ Soc Peripher Vasc Nurs. 2019;37(2):117–124. doi:10.1016/j.jvn.2019.02.002
  • Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:16.
  • Piotrowski W, Waśkiewicz A, Cicha-Mikołajczyk A. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies. Kardiol Pol. 2016;74(3):262–273. doi:10.5603/KP.a2015.017526365939
  • Dhingra R, Vasan RS. Age as a cardiovascular risk factor. Med Clin North Am. 2012;96(1):87–91. doi:10.1016/j.mcna.2011.11.00322391253
  • Tuomilehto J. Impact of age on cardiovascular risk: implications for cardiovascular disease management. Atheroscler Suppl. 2004;5(2):9–17. doi:10.1016/j.atherosclerosissup.2004.03.00615121030
  • Lewington S, Clarke R, Qizilbash N. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913. doi:10.1016/S0140-6736(02)11911-812493255
  • Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623–1630. doi:10.1016/S0140-6736(02)11600-X12457784
  • Casiglia E, Mazza A, Tikhonoff V, Scarpa R, Schiavon L, Pessina AC. Total cholesterol and mortality in the elderly. J Intern Med. 2003;254(4):353–362. doi:10.1046/j.1365-2796.2003.01200.x12974874
  • Yakaryılmaz FD, Öztürk ZA. Treatment of type 2 diabetes mellitus in the elderly. World J Diabetes. 2017;8(6):278–285. doi:10.4239/wjd.v8.i6.27828694928
  • Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet. 2008;371(9623):1547–1549. doi:10.1016/S0140-6736(08)60313-X18321568
  • Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113(6):791–798. doi:10.1161/CIRCULATIONAHA.105.54820616461820
  • Terry DF, Pencina MJ, Vasan RS, et al. Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants. J Am Geriatr Soc. 2005;53(11):1944–1950. doi:10.1111/j.1532-5415.2005.00465.x16274376
  • Ungar A, Galizia G, Morrione A, et al. Two-year morbidity and mortality in elderly patients with syncope. Age Ageing. 2011;40(6):696–702. doi:10.1093/ageing/afr10921908471
  • Cochrane T, Davey R, Gidlow C, et al. Contribution of individual risk factor changes to reductions in population absolute cardiovascular risk. Biomed Res Int. 2014;2014:1–6. doi:10.1155/2014/626205
  • Quispe R, Bazo‐Alvarez JC, Burroughs Peña MS, et al. Distribution of short‐term and lifetime predicted risks of cardiovascular diseases in peruvian adults. J Am Heart Assoc. 2015;4(8). doi:10.1161/JAHA.115.002112
  • Loria CM, Liu K, Lewis CE, et al. Early adult risk factor levels and subsequent coronary artery calcification. J Am Coll Cardiol. 2007;49(20):2013–2020. doi:10.1016/j.jacc.2007.03.00917512357
  • Hajar R. Risk factors for coronary artery disease: historical perspectives. Heart Views. 2017;18(3):109. doi:10.4103/HEARTVIEWS.HEARTVIEWS_106_1729184622
  • Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular disease. N Engl J Med. 2012;366(4):321–329. doi:10.1056/NEJMoa101284822276822
  • Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the american heart association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613. doi:10.1161/CIRCULATIONAHA.109.19270320089546